Reactivation of organophosphate-inhibited acetylcholinesterase by quaternary pyridinium aldoximes

Neurotoxicity Research

Volumn 6, Issue 7-8, 2004, Pages 565-570

  Kuca, Kamil ^a   Patocka, Jirí ^a,b   Cabal, Jirí ^a   Jun, Daniel ^a,c  

^a Institute of Radiobiology and Immunology   (Czech Republic)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^c Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

2 PAM; Acetylcholinesterase; HI 6; HS 6; Inhibition; Nerv eagents; Obidoxime; Organophosphorus compounds; Reactivation

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; CHOLINESTERASE REACTIVATOR; ORGANOPHOSPHATE; OXIME; PYRIDINIUM DERIVATIVE;

ANIMAL; ARTICLE; BRAIN; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; RAT;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; OXIMES; PHOSPHORIC ACID ESTERS; PYRIDINIUM COMPOUNDS; RATS;

EID: 15844422691     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033452     Document Type: Article

References (23)

1. Cabal J, K Kuca and J Kassa (2004) Specification of the structure of oximes able to reactivate tabun inhibited acetylcholinesterase. Basic Clin. Pharmacol. Toxicol. 95, 81-86.
2. Dawson RM (1994) Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14, 317-331.
3. De Jong LPA, HP Benschop, GR Van Den Berg, GZ Wolring and DC Korte (1981) Reactivation of tabun-inhibited acetyl cholinesterase by 1-(hetero)arylmethyl-pyridinium-oximes. Eur. J. Med. Chem. - Chim. Therap. 16, 257-262.
4. Kassa J (2002) Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40, 803-816.
5. Kassa J and J Cabal (1999a) A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF Agent) by in vitro and in vivo methods. Pharmacol. Toxicol. 84, 41-45.
6. Kassa J and J Cabal (1999b) A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum. Exp. Toxicol. 18, 560-565.
7. Kuca K and J Kassa (2003) A comparison of the ability of a new byspyridinium oxime-1-(hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzyme Inhib. Med. Chem. 18, 529-535.
8. Kuca K and J Kassa (2004) Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent. Hum. Exp. Toxicol. 23, 167-171.
9. Kuca K, J Bielavsk, J Cabal and J Kassa (2003a) Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 13, 3545-3547.
10. Kuca K, J Bielavsk, J Cabal and M Bielavská (2003b) "Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxy-iminomethylpyridinium)-3 -(carbamoyl pyridinium)-propane dibromide. Tetrahedron Lett. 44, 3123-3125.
11. Kuca K, J Cabal, J Patocka and V Dohnal (2004a) Quaternary heteroarenium salts as the competitive inhibitors of the brain acetylcholinesterase. Lett. Drug Des. Disc. 1, 97-100.
12. Luo Ch, H Leader, Z Radic, DM Maxwell, P Taylor, BP Doctor and A Saxena (2003) Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase. Biochem. Pharmacol. 66, 387-392.
13. Marrs TC (1993) Organophosphate poisoning. Pharmacol. Ther. 58, 51-66.
14. Pang YP, TM Kollmeyer, F Hong, J Ch Lee, PL Hammond, SP Haugabouk and S Brimijoin (2003) Rational design of alkylenelinked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem. Biol. 10, 491-502.
15. Patocka J, J Bielavsk and F Ornst (1970) Reactivating effect of alpha, omega-bis-(4-pyridinealdoxime)-2-trans-butene dibromide on isopropyl-methylphosphonylated acetylcholinesterase. FEBSLett. 5, 182-184.
16. Puu G, E Artursson and G Bucht (1986) Reactivation of nerve agent inhibited human acetylcholinesterase by HI-6 and obidoxime. Biochem. Pharmacol. 35, 1505-1510.
17. ěvcíková K, F Hampl, F Liπka, J Cabal and J Patocka (1998) Substituted pyridinium derivatives as inhibitors of acetylcholinesterase. Voj. Zdrav. Listy - Suppl. 67, 28-31.
18. Tallarida R and R Murray (1987) Manual of Pharmacological Calculation with Computer Programs (Springer: New York), p 145.
19. Taylor P (1996) Anticholinergic agents, In The Pharmacological Basis of Therapeutics (Hardman JG and LE Limbird, Eds.) (McGraw Hill: New York), pp 161-176.
20. Tuπarová I, E Halámek and Z Kobliha (1999) Study on reactivation of enzyme-inhibitor complexes by oximes using acetylcholin esterase inhibited by organophosphate chemical warfare agents. Enzyme Microb. Technol. 25, 400-403.
21. Worek F, M Backer, H Thiermann, L Szinicz, U Mast, R Klimmek and P Eyer (1997) Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 16, 466-472.
22. Worek F, R Widmann, O Knopffand and L Szinicz (1998) Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch. Toxicol. 72, 237-243.
23. Yang GY, JH Yoon, CM Seong, NS Park and YS Jung (2003) Synthesis of bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophosphate nerve agents. Bull. Korean Chem. Soc. 24, 1368-1370.